Abstract:BackgroundChronic cough affects more than 70 percent of patients with Idiopathic Pulmonary Fibrosis and causes significant morbidity. Gastroesophageal reflux is the cause of some cases of chronic cough; and also has a postulated role in the aetiology of Idiopathic Pulmonary Fibrosis. A high prevalence of acid; and more recently non-acid, reflux has been observed in Idiopathic Pulmonary Fibrosis cohorts. Therefore, gastroesophageal reflux may be implicated in the pathogenesis of cough in Idiopathic Pulmonary Fibrosis.MethodsEighteen subjects with Idiopathic Pulmonary Fibrosis underwent 24-hour oesophageal impedance and cough count monitoring after the careful exclusion of causes of chronic cough other than gastroesophageal reflux. All 18 were then treated with high dose acid suppression therapies. Fourteen subjects underwent repeat 24-hour oesophageal impedance and cough count monitoring after eight weeks.ResultsTotal reflux and acid reflux frequencies were within the normal range in the majority of this cohort. The frequencies of non-acid and proximal reflux events were above the normal range. Following high dose acid suppression therapy there was a significant decrease in the number of acid reflux events (p = 0.02), but an increase in the number of non-acid reflux events (p = 0.01). There was no change in cough frequency (p = 0.70).ConclusionsThis study confirms that non-acid reflux is prevalent; and that proximal oesophageal reflux occurs in the majority, of subjects with Idiopathic Pulmonary Fibrosis. It is the first study to investigate the effect of acid suppression therapy on gastroesophageal reflux and cough in patients with Idiopathic Pulmonary Fibrosis. The observation that cough frequency does not improve despite verifiable reductions in oesophageal acid exposure challenges the role of acid reflux in Idiopathic Pulmonary Fibrosis associated cough. The finding that non-acid reflux is increased following the use of acid suppression therapies cautions against the widespread use of acid suppression in patients with Idiopathic Pulmonary Fibrosis given the potential role for non-acid reflux in the pathogenesis of cough and Idiopathic Pulmonary Fibrosis itself.Study registrationThe study was registered with the Cardiff and Vale University Local Health Board Research and Development Committee (09/CMC/4619) and the South East Wales Ethics Committee (09/WSE04/57).

What causes cough in pulmonary fibrosis, and how should we treat it?

Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease

Managing Cough in Idiopathic Pulmonary Fibrosis

Research advance on interstitial lung disease associated cough

The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis

Mechanisms and management of cough in interstitial lung disease

Cough in chronic lung disease: a state of the art review

Determinants of cough-related quality of life in interstitial lung diseases

Effect of acid suppression therapy on gastroesophageal reflux and cough in idiopathic pulmonary fibrosis: an intervention study

Lung Cancer and Interstitial Lung Diseases

Objective measurement of cough in pulmonary fibrosis: a cohort study - ImpaCT

The Role of Lung Microbiome in Fibrotic Interstitial Lung Disease—A Systematic Review

Immune mechanisms in fibrotic interstitial lung disease

Immunomodulatory treatment of interstitial lung disease

Characteristics of idiopathic pulmonary fibrosis -associated cough. a case-control study

Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities

Pulmonary Hypertension in Interstitial Lung Disease: A Systematic Review and Meta-Analysis

Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival

Interstitial lung diseases: never forget to think about it in primary care

Progression of fibrosing interstitial lung disease

Environmental, Inhaled and Ingested Causes of Pulmonary Fibrosis